Press release

Patientenrekrutierung der Phase III-ARISER-Studie mit RENCAREX® erfolgreich abgeschlossen

(pressebox) München, 03.07.2008 - Das Münchener biopharmazeutische Unternehmen WILEX AG (ISIN DE0006614720 / Frankfurter Wertpapierbörse / Prime Standard) gibt bekannt, dass die Patientenrekrutierung...

This press release has not been activated yet.
Unfortunately, this company press room has not been activated yet for the unlimited access by journalists.

Request press release
The up to date chosen press release can be requested directly from the editor via the following form:

Activate your press room:
As publisher of this press release, you have the possibility to activate it for free public access. Please have a look at affordable prices.

Recommend

Trackback